The way in which a suspension nasal spray product interacts with the body depends not only on the droplet size of the delivered droplet, but also on the particle size of the suspended API.
Technology advances foster new therapies.
Dave Wood, CEO at Experic, discusses how decades of expertise with advanced technologies helps pharmaceutical and biotech partners bring products to market faster.
A thoughtfully constructed QRM Master Plan translates the strategy and enables a risk-based approach.
A book offers a detailed introduction to the new area of risk evaluation and mitigation strategies.
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
Liposome extruders are mainly used for the liposome formulation and achieving uniform size distributions. It is an ideal instrument to generate nanoscale liposome formulations, and to prepare exosomes and artificial cell membranes. By utilizing the tracked-etched filter membranes, the liposome extruders are capable
India has evolved from a low-cost region to an area with extensive technical capability and high quality standards.
Polyethylene glycol (PEG) conjugation is a highly effective technical and commercial strategy to develop macromolecules. The authors explain the benefits and process of PEGylation and how it may be applied to small molecules.
The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.
AFI representatives of the process validation working group explore and define key elements for an enhanced approach to process validation for sterile liquid and freeze-dried forms.
There is a need for current cleaning validation methods to be used for topical formulations. The authors highlight the issues and challenges encountered.
Pelletization, a popular oral drug delivery method in pharmaceuticals and nutraceuticals, offers numerous benefits. This article delves into the critical parameters for formulation development and technological consideration in pelletization, elucidating its significance in advancing pharmaceutical solutions.
Stevanato Group’s integrated offering addressing mAbs challenges includes Aidaptus®, a 2-step single-use auto-injector accommodating 1mL and 2.25mL PFSs in the same base device, supporting a range of drug viscosities for reliable delivery.
By taking a strategic and evidence-based approach, companies can leverage the insights gained from stability studies to establish robust labeling.
The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.
Nano PharmaSolutions developed a new nanoformulation for improving solubility of drug molecules, which can save several months of preclinical stage of drug development.
Optimizing the use of partners for clinical trials depends on selecting the right contractor.
FDA's approval will allow Kedrion to manufacture Ryplazim (plasminogen, human-tvmh), the only FDA-approved therapy for treating PLGD-1, at facility in Bolognana, Italy.
Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure accurate documentation, and strengthen data integrity.
Researchers demonstrated a new cell lysis method using a novel solution to improve viral vector production.
The authors describe the factors affecting reconstitution time of dry powder for injection and classifies them as intrinsic and extrinsic parameters.
User fee programs have improved FDA’s approval timeline for important therapies.
The “cloud lab” is a virtual laboratory setting that can enable scientists to more quickly advance research.
Industry should improve the standards on application of risk management tools in light of the cases of nitrosamine impurities.
Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.
Having a robust Cell Line Development (CLD) strategy is the foundation of biologic production that can propel a project, helping to streamline production while mitigating risk. A tailored and optimized cell line can be instrumental in overcoming development and manufacturing challenges and achieving a competitive advantage in the market with streamlined manufacturing processes. In this eBook, Bora Biologics describes how a robust CLD strategy can help biologics developers anticipate and overcome challenges and streamline production.
Method-transfer kits help simplify analytical method transfer for global site certifications.